Abstract
The capacity of trehalose dimycolate (TDM), muramyl dipeptide (MDP), and dimethyl dioctadecyl ammonium bromide (DDA)--alone or in combination--to potentiate the immunogenicity of killed Brucella abortus 45/20 bacteria was studied in guinea pigs. Bacterins that contained TDM in oil droplet emulsion were as effective in the prevention of brucellosis as those emulsified in Freund complete adjuvant, wereas bacterins that contained a combination of TDM and MDP were most effective. Vaccinal emulsions of bacteria and MDP were ineffective in the prevention of splenic infections. Likewise, DDA was unable to potentiate acquired resistance to Brucella. Addition of DDA to 1% oil emulsions of bacteria, TDM, and MDP eliminated protection. Adjuvants without bacteria were not able to nonspecifically protect animals from infection, although TDM was able to significantly reduce the numbers of splenic Brucella. A positive correlation (P < 0.0001) between splenic infection and splenic weight was found.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chedid L., Carelli C., Audibert F. Recent developments concerning muramyl dipeptide, a synthetic immunoregulating molecule. J Reticuloendothel Soc. 1979 Dec;26(Suppl):631–641. [PubMed] [Google Scholar]
- Desowitz R. S., Barnwell J. W. Effect of selenium and dimethyl dioctadecyl ammonium bromide on the vaccine-induced immunity of Swiss-Webster mice against malaria (Plasmodium berghei). Infect Immun. 1980 Jan;27(1):87–89. doi: 10.1128/iai.27.1.87-89.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ellouz F., Adam A., Ciorbaru R., Lederer E. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res Commun. 1974 Aug 19;59(4):1317–1325. doi: 10.1016/0006-291x(74)90458-6. [DOI] [PubMed] [Google Scholar]
- Granger D. L., Yamamoto K. I., Ribi E. Delayed hypersensitivity and granulomatous response after immunization with protein antigens associated with a mycobacterial glycolipid and oil droplets. J Immunol. 1976 Feb;116(2):482–488. [PubMed] [Google Scholar]
- Kotani S., Watanabe Y., Kinoshita F., Shimono T., Morisaki I. Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids. Biken J. 1975 Jun;18(2):105–111. [PubMed] [Google Scholar]
- Masek K., Zaoral M., Jezek J., Straka R. Immunoadjuvant activity of synthetic N-acetyl muramyl dipeptide. Experientia. 1978 Oct 15;34(10):1363–1364. doi: 10.1007/BF01981474. [DOI] [PubMed] [Google Scholar]
- McLaughlin C. A., Schwartzman S. M., Horner B. L., Jones G. H., Moffatt J. G., Nestor J. J., Jr, Tegg D. Regression of tumors in guinea pigs after treatment with synthetic muramyl dipeptides and trehalose dimycolate. Science. 1980 Apr 25;208(4442):415–416. doi: 10.1126/science.7189295. [DOI] [PubMed] [Google Scholar]
- Van Der Meer C., Hofhuis F. M., Willers J. M. Delayed-type hypersensitivity and acquired cellular resistance in mice immunized with killed Listeria monocytogenes and adjuvants. Immunology. 1979 May;37(1):77–82. [PMC free article] [PubMed] [Google Scholar]
- Woodard L. F., Renshaw H. W., Burger D. Cell-mediated immunity in neonatal calves: delayed-type hypersensitivity and lymphocyte blastogenesis following immunization with a mycobacterial immunopotentiating glycolipid and tuberculoproteins of Mycobacterium bovis. Am J Vet Res. 1978 Apr;39(4):579–584. [PubMed] [Google Scholar]
- Woodard L. F., Toone N. M., McLaughlin C. A. Immunogenic properties of soluble antigens or whole cells of Brucella abortus strain 45/20 associated with immunoadjuvants. II. Whole cells. Can J Comp Med. 1980 Oct;44(4):456–458. [PMC free article] [PubMed] [Google Scholar]
- Yamamura Y., Azuma I., Sugimura K., Yamawaki M., Uemiya M. Adjuvant activity of 6-O-mycoloyl-N-acetylmuramuyl-L-alanyl-D-isoglutamine. Gan. 1976 Dec;67(6):867–877. [PubMed] [Google Scholar]